Therapeutic Potential of Naltrexone in the Niche of Psychopharmacology.
Psychopharmacol Bull
; 54(3): 97-99, 2024 Jul 08.
Article
em En
| MEDLINE
| ID: mdl-38993658
ABSTRACT
NTX is FDA-approved for opiate and alcohol use disorders as anti-craving agent. It has been used successfully off-label in other psychiatric indications. Here, we shed some light on these while examining the extant evidence.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Naltrexona
/
Antagonistas de Entorpecentes
Limite:
Animals
/
Humans
Idioma:
En
Revista:
Psychopharmacol Bull
Ano de publicação:
2024
Tipo de documento:
Article